Cocaine as a risk factor for neuroleptic-induced acute dystonia

The Journal of Clinical Psychiatry
P N van HartenH W Hoek

Abstract

A prospective study was conducted to test the hypothesis that cocaine use is a risk factor for neuroleptic-induced acute dystonia (NIAD). The study sample consisted of a high-risk group for NIAD, males aged 17-45 years who had received high-potency neuroleptics within 24 hours of admission and had not used neuroleptics in the month prior to admission. Patients were excluded if they suffered from a neurodegenerative disorder or were exposed to anticholinergics, benzodiazepines, promethazine, carbamazepine, phenytoin, or levodopa during the study. Twenty-nine patients--9 cocaine users and 20 nonusers--entered the study, which lasted 2 years. Patients were followed for 7 days. Cocaine-using psychiatric patients developed significantly more NIAD than did nonusers (relative risk = 4.4, 95% CI = 1.4 to 13.9). Cocaine use is a major risk factor for NIAD and should be added to the list of well-known risk factors. The authors strongly suggest that cocaine-using psychiatric patients who are started on a regimen of neuroleptics should also be administered an anticholinergic for at least 7 days to prevent NIAD.

Citations

Jun 30, 2005·Journal of Psychiatric Practice·Michael H AllenRuth Ross
Dec 18, 2007·Psychiatry and Clinical Neurosciences·Nobutomo YamamotoToshiya Inada
Sep 3, 1999·BMJ : British Medical Journal·P N van HartenR S Kahn
May 18, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·S PotvinE Stip
Nov 30, 2014·Neurologic Clinics·Shyamal H MehtaKapil D Sethi
Jan 12, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·David J VinkersPeter N van Harten
May 9, 2007·General Hospital Psychiatry·Harpreet S Duggal
Mar 9, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Harpreet Singh Duggal
Apr 3, 2012·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Haifeng HouHong Zhang
Jul 30, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Simon ZhornitskyStéphane Potvin
Mar 28, 2013·Human Psychopharmacology·Lars K HansenDavid Kingdon
Jul 23, 2004·Expert Opinion on Drug Safety·John H ShaleWilliam D Mastin
Sep 10, 2020·Journal of Psychopharmacology·Anton Jm Loonen, Svetlana A Ivanova
Dec 2, 2005·Journal of Psychiatric Practice·Michael H AllenUNKNOWN Expert Consensus Panel for Behavioral Emergencies 2005
Apr 24, 2010·CNS Spectrums·Icro MaremmaniHagop Akiskal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Related Papers

The American Journal of Emergency Medicine
R E FinesD J DeBehnke
BMJ : British Medical Journal
Angela J Robinson, Brian G Gazzard
The British Journal of Psychiatry : the Journal of Mental Science
R GrayS Oxborrow
© 2022 Meta ULC. All rights reserved